U.K. (FTSE) Clinical Research and Equipment Industry Analysis
UpdatedMay 09, 2024
DataAggregated Company Financials
Companies9
- 7D13.5%
- 3M-18.5%
- 1Y-40.1%
- YTDn/a
The Clinical Research and Equipment industry is up 13% in the last week, with MaxCyte up 33%. However, the industry is down 40% over the past year. Looking forward, earnings are forecast to grow by 16% annually.
Industry Valuation and Performance
Has the U.K. Clinical Research and Equipment Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 10 May 2024 | UK£1.6b | UK£295.2m | -UK£187,937,536.07 | 6867.6x | -8.5x | 5.4x |
| Sun, 07 Apr 2024 | UK£1.7b | UK£319.1m | -UK£191,365,932.27 | 69.8x | -8.7x | 5.2x |
| Tue, 05 Mar 2024 | UK£1.8b | UK£285.7m | -UK£189,163,354.53 | 6750.9x | -9.5x | 6.3x |
| Thu, 01 Feb 2024 | UK£2.9b | UK£450.3m | -UK£176,657,558.00 | 69.3x | -16.2x | 6.4x |
| Sat, 30 Dec 2023 | UK£3.2b | UK£449.9m | -UK£173,922,769.00 | 56.2x | -18.3x | 7.1x |
| Mon, 27 Nov 2023 | UK£3.0b | UK£455.4m | -UK£168,510,998.00 | 49.9x | -17.9x | 6.6x |
| Wed, 25 Oct 2023 | UK£3.1b | UK£458.5m | -UK£165,458,324.00 | 47.1x | -18.9x | 6.8x |
| Fri, 22 Sep 2023 | UK£3.1b | UK£440.9m | -UK£167,332,420.00 | 67.5x | -18.3x | 7x |
| Sun, 20 Aug 2023 | UK£3.1b | UK£476.1m | -UK£126,481,538.00 | 70.6x | -24.3x | 6.4x |
| Tue, 18 Jul 2023 | UK£3.3b | UK£475.7m | -UK£124,096,359.00 | 65.2x | -26.7x | 7x |
| Thu, 15 Jun 2023 | UK£3.1b | UK£476.6m | -UK£124,793,089.00 | 66.1x | -24.9x | 6.5x |
| Sat, 13 May 2023 | UK£3.2b | UK£477.8m | -UK£122,791,446.00 | 36.7x | -26x | 6.7x |
| Mon, 10 Apr 2023 | UK£3.0b | UK£458.8m | -UK£118,909,403.00 | 33.1x | -25.2x | 6.5x |
| Wed, 08 Mar 2023 | UK£3.1b | UK£444.2m | -UK£183,430,044.00 | 43.7x | -16.7x | 6.9x |
| Fri, 03 Feb 2023 | UK£3.5b | UK£443.1m | -UK£182,775,096.00 | 45.5x | -19.2x | 7.9x |
| Sun, 01 Jan 2023 | UK£3.4b | UK£443.6m | -UK£182,969,144.00 | 47.8x | -18.3x | 7.6x |
| Tue, 29 Nov 2022 | UK£3.6b | UK£446.9m | -UK£179,183,960.00 | 49.1x | -20x | 8x |
| Thu, 27 Oct 2022 | UK£3.7b | UK£448.0m | -UK£175,976,511.00 | 44.4x | -21.2x | 8.3x |
| Sat, 24 Sep 2022 | UK£3.4b | UK£434.6m | -UK£177,287,968.00 | 45.7x | -19.3x | 7.9x |
| Mon, 22 Aug 2022 | UK£4.0b | UK£369.5m | -UK£191,630,387.00 | 50.3x | -21x | 10.9x |
| Wed, 20 Jul 2022 | UK£3.5b | UK£367.2m | -UK£188,315,171.00 | 38.1x | -18.8x | 9.6x |
| Fri, 17 Jun 2022 | UK£3.7b | UK£363.7m | -UK£189,424,698.00 | 37.7x | -19.7x | 10.3x |
| Sun, 15 May 2022 | UK£3.6b | UK£362.0m | -UK£191,849,667.00 | 39.9x | -18.7x | 9.9x |
| Tue, 12 Apr 2022 | UK£6.3b | UK£929.9m | -UK£312,593,492.00 | 49.6x | -20.1x | 6.8x |
| Thu, 10 Mar 2022 | UK£6.3b | UK£891.7m | -UK£201,877,513.00 | 43.5x | -31.4x | 7.1x |
| Sat, 05 Feb 2022 | UK£7.5b | UK£848.8m | -UK£185,968,314.00 | 30.6x | -40.5x | 8.9x |
| Mon, 03 Jan 2022 | UK£9.8b | UK£849.0m | -UK£184,734,302.00 | 30.8x | -53.2x | 11.6x |
| Wed, 01 Dec 2021 | UK£9.1b | UK£844.3m | -UK£191,991,391.00 | 20.1x | -47.6x | 10.8x |
| Fri, 29 Oct 2021 | UK£8.2b | UK£840.6m | -UK£200,478,643.00 | 26.1x | -41.1x | 9.8x |
| Sun, 26 Sep 2021 | UK£3.1b | UK£690.4m | -UK£130,318,119.00 | 29.8x | -23.6x | 4.5x |
| Tue, 24 Aug 2021 | UK£3.0b | UK£670.4m | -UK£160,499,800.35 | 65.8x | -18.6x | 4.5x |
| Wed, 30 Jun 2021 | UK£3.0b | UK£670.4m | -UK£160,499,800.35 | 61.5x | -18.6x | 4.5x |
Price to Earnings Ratio
-40.4x
Current Industry PE
- Investors are pessimistic on the British Life Sciences Tools and Services industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The 3-year average PS ratio of 8.6x is higher than the industry's current PS ratio of 5.4x.
Past Earnings Growth
- The earnings for companies in the Life Sciences Tools and Services industry have deteriorated over the last three years.
- Revenues have also declined 24% per year.
- This means overall sales from these companies are declining and losses are subsequently expanding as well.
Industry Comparison
How does U.K. Clinical Research and Equipment compare with similar industries?
| GB Market | 2.66% | |
| Healthcare | 1.91% | |
| Life Sciences | 13.48% | |
| Clinical Research and Equipment | 13.48% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| MXCT MaxCyte | UK£3.65 | 22.9% +UK£71.1m | 16.8% | PS10.8x | |
| ONT Oxford Nanopore Technologies | UK£1.13 | 6.1% +UK£56.1m | -54.7% | PS5.7x | |
| ERGO Ergomed | UK£13.46 | 0.1% +UK£14.7m | 3.5% | PE46.7x | |
| C4XD C4X Discovery Holdings | UK£0.12 | 45.9% +UK£9.5m | -16.4% | PE2.9x | |
| HVO hVIVO | UK£0.28 | 0.2% +UK£340.2k | 71.0% | PE11.8x |